KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cvs Health (CVS) Enterprise Value (2016 - 2025)

Cvs Health (CVS) has disclosed Enterprise Value for 17 consecutive years, with -$10.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value rose 3.63% year-over-year to -$10.4 billion, compared with a TTM value of -$10.4 billion through Dec 2025, up 3.63%, and an annual FY2025 reading of -$10.4 billion, up 3.63% over the prior year.
  • Enterprise Value was -$10.4 billion for Q4 2025 at Cvs Health, up from -$11.0 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$8.5 billion in Q1 2021 and bottomed at -$19.7 billion in Q3 2022.
  • Average Enterprise Value over 5 years is -$13.1 billion, with a median of -$12.5 billion recorded in 2021.
  • The sharpest move saw Enterprise Value surged 42.77% in 2021, then crashed 58.83% in 2023.
  • Year by year, Enterprise Value stood at -$12.2 billion in 2021, then decreased by 26.22% to -$15.4 billion in 2022, then rose by 26.86% to -$11.3 billion in 2023, then grew by 4.05% to -$10.8 billion in 2024, then grew by 3.63% to -$10.4 billion in 2025.
  • Business Quant data shows Enterprise Value for CVS at -$10.4 billion in Q4 2025, -$11.0 billion in Q3 2025, and -$14.0 billion in Q2 2025.